Elevation Oncology, Inc.
ELEV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,485 | -$45,704 | -$95,080 | -$32,039 |
| Dep. & Amort. | $24 | $39 | $27 | $18 |
| Deferred Tax | $0 | $0 | $0 | -$1,637 |
| Stock-Based Comp. | $4,280 | $3,335 | $3,206 | $1,571 |
| Change in WC | $3,839 | -$13,690 | $6,290 | $283 |
| Other Non-Cash | -$22 | -$160 | $74 | $1,637 |
| Operating Cash Flow | -$36,364 | -$56,180 | -$85,483 | -$30,167 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$86 | $0 |
| Net Acquisitions | $0 | $0 | $44 | $0 |
| Inv. Purchases | -$69,565 | -$42,657 | -$112,312 | $0 |
| Inv. Sales/Matur. | $61,200 | $54,200 | $68,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$44 | $0 |
| Investing Cash Flow | -$8,365 | $11,543 | -$44,398 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $30,000 | $0 |
| Stock Issued | $44,207 | $46,503 | $19 | $97,062 |
| Stock Repurch. | -$48 | -$24 | -$35 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $779 | $1,496 | -$451 | -$11 |
| Financing Cash Flow | $44,938 | $47,975 | $29,514 | $97,051 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $209 | $3,338 | -$100,367 | $66,884 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49,255 | $45,917 | $146,284 | $79,400 |
| End Cash | $49,464 | $49,255 | $45,917 | $146,284 |
| Free Cash Flow | -$36,364 | -$56,180 | -$85,569 | -$30,167 |